帕里塔普雷维尔作为一种泛抗病毒药物,可以对抗不同类型的黄病毒病毒
1Discipline of Natural Sciences, Indian Institute of Information Technology, Design and Manufacturing, Jabalpur, India.
Frontiers in molecular biosciences
|April 18, 2025
概括
针对寨卡病毒,西尼罗河和登革热病毒的抗病毒药物如Ritonavir和Paritaprevir的重新使用显示出有希望. 帕里塔普雷维尔显示出强大的泛抗病毒活性,为这些病毒感染提供了潜在的治疗方法.
科学领域:
- 病毒学 病毒学
- 药物发现 药物发现 药物发现
- 计算化学的计算化学
背景情况:
- 像寨卡病毒 (ZIKV),登革热 (DENV) 和西尼罗河病毒 (WNV) 这样的病毒感染对全球健康构成重大威胁.
- 目前的治疗方法有限,需要识别新型治疗剂.
- 病毒蛋白酶是抗病毒药物开发的关键目标.
研究的目的:
- 为了确定可以抑制ZIKV,DENV和WNV蛋白酶的现有抗病毒药物.
- 评估重新定制药物的结合亲和力和有效性,以对抗弗拉维病毒蛋白酶.
- 探索潜在的泛抗病毒药物用于治疗多种黄病毒感染.
主要方法:
- 使用GOLD 5.0进行分子对接,对20种HIV和HCV药物进行针对ZIKV蛋白酶的查.
- 用AMBER ff14SB力场对药物结合复合体进行分子动力学模拟.
- 使用MM/PBSA方法进行具有约束力的免费能源计算.
主要成果:
- 五种药物表现出与ZIKV蛋白酶的高结合亲缘关系.
- 里托纳维尔和帕里塔普雷维尔对ZIKV NS2B-NS3蛋白酶具有强烈的结合.
- 帕里塔普雷维尔对DENV和WNV蛋白酶有强烈的结合,这表明它具有泛抗病毒活性.
结论:
- 里托纳维尔和帕里塔普雷维尔是ZIKV蛋白酶的有效抑制剂.
- 帕里塔普雷维尔显示出作为一种针对ZIKV,DENV和WNV的广泛抗病毒药物的潜力.
- 药物重定向为开发新治疗法提供了一个可行的策略,用于治疗弗拉维病毒疾病.
相关概念视频
Retroviruses
12.1K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
12.1K
Retrovirus Life Cycles
45.4K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.4K
Cross-reactivity
30.9K
Overview
30.9K


